Prevalence of condition-related healthcare resource use during the follow-up period
| Study cohort | Standardised difference¶ | ||
| Asthma | Non-asthma# | ||
| Subjects | 134 941 | 134 941 | |
| Overall | 98.9% | 95.8% | 0.19 |
| Respiratory diseases other than asthma | 84.9% | 63.4% | 0.51 |
| Infectious and parasitic diseases | 48.3% | 42.7% | 0.11 |
| Digestive disorders | 43.4% | 39.5% | 0.08 |
| Eye, ear, nose | 66.9% | 64.2% | 0.06 |
| Diseases of musculoskeletal and connective tissue | 61.0% | 58.1% | 0.06 |
| Psychiatric disorders | 46.9% | 44.0% | 0.06 |
| Diseases of nervous system | 47.5% | 45.3% | 0.04 |
| Diseases of circulatory system | 31.6% | 30.3% | 0.03 |
| Complications related to congenital abnormalities | 4.2% | 3.6% | 0.03 |
| Hematologic disorders | 12.7% | 11.9% | 0.02 |
| Perinatal-originated conditions | 2.1% | 1.9% | 0.01 |
| Diseases of skin and subcutaneous tissue | 69.1% | 69.6% | −0.01 |
| Endocrine, nutritional and metabolic diseases | 67.5% | 68.4% | −0.02 |
| Genitourinary diseases | 55.2% | 56.9% | −0.03 |
| Neoplasms | 22.9% | 26.3% | −0.08 |
| Pregnancy, childbirth and puerperium | 7.7% | 10.5% | −0.10 |
#: from 31 372 unique individuals selected with replacement for matching. ¶: difference in means or proportions divided by standard error. Imbalance was defined as absolute value >0.10.